Acquisition Opportunity The Conference Forum was acquired by Questex Travel Group in November 2025, signaling a significant corporate consolidation in life science events. This presents a potential cross-sell to Questex portfolios and access to expanded distribution channels and customer bases.

Lifecycle Events Their core business is developing specialized life science conferences aimed at accelerating patient access to therapeutics, with ongoing event programs like CMO Summit 360 and Patients as Partners. This suggests opportunities for sponsored content, speaker programs, and co-branded sessions with pharma, biotech, and CROs.

Target Audience Primary audience includes pharmaceutical and biotech professionals, including Chief Medical Officers and other executives, indicating high-value, senior-level engagement opportunities for executive briefings, advisory boards, and premium networking formats.

Digital & Tech Tech stack includes Drupal, Cloudflare, and performance/visibility tooling, signaling openness to digital advertising, sponsor portals, and enhanced on-site or virtual event tech partnerships to improve attendee experience.

Small Firm Advantage Smaller team size (2-10 employees) combined with revenue under $1M but with growth through strategic events presents an opening for scalable, cost-efficient partnerships, sponsorship packages, and tiered engagement options tailored to a boutique, high-touch sales approach.